Results 1 to 10 of about 3,981 (70)

Transcatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Transcatheter aortic valve replacement with supra‐annular transcatheter heart valves has been adopted in patients with degenerated surgical aortic valves.
Luis Augusto P. Dallan, John K. Forrest, Michael J. Reardon, Wilson Y. Szeto, Isaac George, Susheel Kodali, Neal S. Kleiman, Steven J. Yakubov, Kendra J. Grubb, Fang Liu, Cristian Baeza, Guilherme F. Attizzani   +11 more
doaj   +1 more source

Transcatheter versus surgical aortic valve replacement for stenotic bicuspid aortic valve: Systematic review and meta-analysisCentral MessagePerspective

JTCVS Open, 2023
Objectives: Bicuspid aortic valves have been excluded from randomized trials comparing transcatheter aortic valve replacement with surgical aortic valve replacement.
Yosuke Sakurai, MD, Yujiro Yokoyama, MD, Toshiki Kuno, MD, PhD, Hisato Takagi, MD, PhD, Amgad Mentias, MD, Vinod H. Thourani, MD, Azeem Latib, MD, Tsuyoshi Kaneko, MD   +7 more
doaj   +1 more source

Transcatheter Versus Surgical Valve Replacement: A 24-months Propensity-matched Analysis of the SILCARD Registry

Anatolian Journal of Cardiology, 2022
Background: Data concerning the comparison between transcatheter aortic valve implantation and surgical aortic valve replacement in a real-world setting are scarce and in Central and Eastern Europe no such data exist. In this study, we aimed at analyzing
Krzysztof Wilczek, Michal Hawranek, Wojciech Wojakowski, Piotr Chodór, Michal Zembala, Pawel Buszman, Andrzej Bochenek, Marek Deja, Maciej Dyrbus, Daniel Ciesla, Zbigniew Kalarus, Mariusz Gasior, Marian Zembala   +12 more
doaj   +1 more source

Challenging Anatomies for TAVR—Bicuspid and Beyond

Frontiers in Cardiovascular Medicine, 2021
Transcatheter aortic valve replacement has emerged as the standard treatment for the majority of patients with symptomatic aortic stenosis. As transcatheter aortic valve replacement expands to patients across all risk groups, optimal patient selection ...
Mohammed Saad, Hatim Seoudy, Hatim Seoudy, Derk Frank, Derk Frank   +4 more
doaj   +1 more source

Advances in Transcatheter Electrosurgery for Treating Valvular Heart Disease

US Cardiology Review, 2021
Delivery of electrosurgery energy through catheters and guidewires enables interventionists to ‘cut’ through obstructive intravascular lesions or across cardiac chambers.
Jaffar M Khan, Toby Rogers, Adam B Greenbaum, Vasilis C Babaliaros, John C Lisko, Dursun Korel Yildirim, Christopher G Bruce, Daniel A Herzka, Kanishka Ratnayaka, Robert J Lederman   +9 more
doaj   +1 more source

Late Type A Dissection After Transfemoral Aortic Valve Replacement

JACC: Case Reports, 2020
An 87-year-old woman had residual moderate to severe aortic insufficiency following transcatheter aortic valve replacement. A year later, she developed extensive Stanford type A aortic dissection originating at the supra-annular aortic edge of the ...
Michael E. Pontious, BS, Awais Ashfaq, MBBS, Justin J. Watson, MD, Howard K. Song, MD, PhD, Cristina Fuss, MD, Scott M. Chadderdon, MD, Castigliano M. Bhamidipati, DO, PhD, MSc   +6 more
doaj   +1 more source

Valve-in-Valve-in-Valve: Degenerated Transcatheter Heart Valve within Degenerated Surgical Bioprosthetic Aortic Valve Treated with Second Transcatheter Heart Valve

Reports, 2020
Currently, transcatheter aortic valve replacements within degenerated surgical bioprosthetic aortic valves (valve in valve) are increasing in frequency with studies supporting their safety and efficacy.
Muhammad Ajmal, Sridhar Reddy, Ranjith Shetty, Toshinobu Kazui, Kapildeo Lotun   +4 more
doaj   +1 more source

Same-Day Discharge After Transcatheter Native Aortic and Mitral Valve-in-Valve Replacement

JACC: Case Reports, 2020
Transcatheter aortic valve replacement has become the gold standard of care in the management of patients with severe aortic stenosis and transcatheter mitral valve-in-valve replacement seems to be an attractive alternative to redo surgery. We report the
Vinayak Nagaraja, MBBS, MS MMed (Clin Epi), Amar Krishnaswamy, MD, James Yun, MD, Samir R. Kapadia, MD   +3 more
doaj   +1 more source

All-cause procedural readmissions following transcatheter aortic valve replacementCentral MessagePerspective

JTCVS Open, 2023
Objective: With expanding eligibility criteria, transcatheter aortic valve replacement is being performed on patients with longer life expectancy, and subsequent procedures after index transcatheter aortic valve replacement are inevitable.
Paige Newell, MD, Hoda Javadikasgari, MD, Mehida Rojas-Alexandre, MD, Sameer Hirji, MD, MPH, Morgan Harloff, MD, Olena Cherkasky, MS, Siobhan McGurk, BS, Alexandra Malarczyk, BS, Pinak Shah, MD, Ashraf Sabe, MD, Tsuyoshi Kaneko, MD   +10 more
doaj   +1 more source

Transapical transcatheter aortic valve implantation in a patient with small body weight complicated by severe hypotension: An enigma successfully solved by echocardiography [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2017
Introduction. Transcatheter aortic valve implantation is currently considered an alternative treatment for older patients with severe aortic valve stenosis and increased surgical risk, but can be associated with multiple life-threatening complications ...
Lazarević Aleksandar, Naganuma Toru, Mitomo Satoru, Kawamoto Hiroyoshi, Nakao Tatsuya, Ishiguro Hisaaki, Nakamura Sunao   +6 more
doaj   +1 more source